The Lundquist Institute

10/08/2026

We're proud to share that The Lundquist Institute received an award from the U.S. Department of Health and Human Services Office of Research Integrity to host "Addressing Emerging Challenges in Research Integrity," a conference helping Southern California research institutions tackle AI, data integrity, and research security together. Led by Rosemary Madnick, MBA.

Details coming soon!

10/08/2026

What does it take to turn scientific discovery into meaningful advances in patient care? 🔬

We're bringing the conversation to Loyola Marymount University!

Join our President and CEO Joe W Ramos, PhD, and leading investigators Denise Al Alam, PhD, and Ashraf Ibrahim, PhD, for Seaver Spotlight as they share insights on biomedical innovation, interdisciplinary collaboration, and the future of health sciences.

Thank you to LMU Seaver College for bringing together scientific leaders and the next generation of innovators!

📅 Thursday, October 15 at 5:00pm PT
🔗 RSVP: https://lnkd.in/dJEeAE2M

10/06/2026

Why do we discover?

For The Lundquist Institute President and CEO Joe W. Ramos, PhD, it begins with curiosity. But what we do with that curiosity is what gives discovery purpose.

In his recent Science and Your Health lecture, “Why We Discover,” Dr. Ramos shares the personal journey that shaped him as a scientist and his vision for turning discovery into meaningful impact.

Get a glimpse of his answer in this clip, then watch the full lecture in our Virtual Innovation Library: Lundquist.org/virtual-innovation-library/

10/05/2026

What if preventing asthma could begin before a child takes their very first breath? 🫁

At The Lundquist Institute, Virender S. Rehan, MD, is investigating how ni****ne va**ng during pregnancy may affect developing lungs and increase the risk of childhood asthma. And, importantly, whether that damage can be prevented.

Backed by a $3.3 million grant from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI), Dr. Rehan’s latest research builds on nearly two decades of work exploring how early-life exposures can shape lung health for years and even generations to come.

"Once the lungs are affected during the developing period, that basically sets the trajectory of the lung function for our whole life," Dr. Rehan explains.

Read more about Dr. Rehan’s research below.

For many children, asthma begins long before their first breath. Virender S. Rehan, MD, a neonatologist and investigator at The Lundquist Institute, is dedicated to understanding the mechanisms in which this occurs and how to prevent it. Dr. Rehan’s work rests on a simple but powerful idea: the l...

09/25/2026

Happy International Research Administrators Day!

Today, we recognize the dedicated professionals who work behind the scenes to help research move forward with integrity, responsibility, efficiency, and extraordinary attention to detail.

To our Research Administrators across The Lundquist Institute: thank you. Your expertise, persistence, and partnership are essential at every stage of the research process—from advancing proposals and awards and navigating regulatory requirements to coordinating resources, supporting clinical trials, and solving challenges along the way.

We also recognize our investigators who work closely with our research administration teams. Strong research depends on strong partnerships. These collaborations allow us to stay focused on what matters most: advancing biomedical science and improving health outcomes for our communities and beyond.

Please join us in celebrating our Research Administrators and thanking them for everything they do to make discovery possible.

09/23/2026

Four Innovation Hubs. Eight leaders. One shared vision for advancing human health. 🔬🧪🧬

Over the past several weeks, we've introduced the Executive Directors leading The Lundquist Institute's four Research Innovation Hubs—bringing together researchers, clinicians, and innovators across disciplines to tackle some of the most pressing challenges in human health.

Through conversations with each of our Hub leaders, we explored the experiences that shaped their work, the challenges they're working to solve, and their vision for turning scientific discovery into meaningful impact. Meet the leaders behind our four Research Innovation Hubs:

Advanced Therapeutics & Biomedical Technologies: bit.ly/4xHbM5l

Infectious Diseases & Immunology: bit.ly/3TgoiKU

Systems Medicine & Precision Prevention: bit.ly/3UYMAcV

Translational Science & Population Health: bit.ly/4AESsIG

09/17/2026

Promising results from a Phase 3 clinical trial could help pave the way for a shorter treatment option for people living with hepatitis C.

The Lundquist Institute Investigator Timothy Hatlen, MD, contributed to the study evaluating an investigational shorter treatment regimen for participants with chronic hepatitis C virus (HCV) infection.

The findings show that a shorter, once-daily regimen could help simplify treatment decisions for clinicians and patients. Streamlined treatment options may also support broader test-and-treat strategies aimed at advancing HCV elimination.

Learn more about the study and Dr. Hatlen’s contributions: https://lundquist.org/news/dr-timothy-hatlen-contributes-to-positive-phase-3-hepatitis-c-trial-results/

09/16/2026

The Lundquist Institute is proud to announce that Investigator Bridgette E. Blebu, PhD MPH has received a three-year R34 grant from the National Heart, Lung, and Blood Institute to advance research aimed at improving preeclampsia prevention.

Preeclampsia, a serious pregnancy complication characterized by high blood pressure. While evidence-based preventive approaches such as daily low-dose aspirin are available, they remain underutilized.

Through this new project, Dr. Blebu will partner with community clinics across Los Angeles County to better understand the clinical, structural, and patient-level factors that can affect how preventive recommendations are put into practice.

Read more about her research below. 🩺

That gap between evidence-based recommendations and their implementation in routine care is the focus of a new three-year R34 award from the National Heart, Lung, and Blood Institute (NHLBI), led by Bridgette Blebu, PhD, MPH, an investigator in the Translational Science and Population Health Innov...

09/14/2026

HIV research has transformed lives over the past four decades, but the work is far from over.

In this special Q&A, Dr. Eric S. Daar shares insights from decades of experience in HIV research and patient care. His work has primarily focused on defining the pathogenesis of acute HIV infection as well as designing clinical trials to optimize treatment and overcome obstacles to maintaining control of HIV in clinical practice.

Watch, share, and join us in creating a more informed and compassionate future.

To learn more about Dr. Daar and his research, visit: lundquist.org/profile/eric-s-daar-md/.